Get complete Patent Opposition Report for Chong Kun Dang Pharmaceutical

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Chong Kun Dang Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3866765Feb 7, 2024Injectable Long-Acting Naltrexone Microparticle Compositions1